
BMS986299
CAS No. 2242952-69-6
BMS986299( Unii-VS58MO4P47 )
Catalog No. M28769 CAS No. 2242952-69-6
BMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 155 | Get Quote |
![]() ![]() |
25MG | 327 | Get Quote |
![]() ![]() |
50MG | 520 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBMS986299
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.
-
DescriptionBMS986299 is a modulator of NLRP3 with an EC50 of 1.28 μM and can be used in studies about NLRP3 signaling and the treatment of associated diseases.
-
In Vitro——
-
In Vivo——
-
SynonymsUnii-VS58MO4P47
-
PathwayNF-κB
-
TargetNOD
-
RecptorCationic Lipid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2242952-69-6
-
Formula Weight349.39
-
Molecular FormulaC18H19N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (95.39 mM)
-
SMILESO=C(N(CC1=NC=2C(=NC=3C=C(C=CC3C2N1)C4=NNC=C4)N)CC)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
NLRP3-IN-9
NLRP3-IN-9 is an inhibitor of NLRP3 ATPase and caspase-1. NLRP3-IN-9 acts by irreversibly trapping thiol nucleophiles, which prevents both ATP- and nigericin-triggered pyroptosis of human THP-1 cells in a time- and concentration-dependent manner.
-
Lobeglitazone Sulfat...
Lobeglitazone Sulfate(CKD-501 Sulfate) is a novel thiazolidinedione with anti-inflammatory activity that inhibits LPS-induced NLRP3 inflammasome activation and hepatic inflammation, and can be used in the study of type 2 diabetes mellitus (T2DM).
-
ADS032
ADS032 (BT-032) is an NLRP1 and NLRP3 inhibitor with anti-inflammatory activity,, inhibits the activation of NLRP1 and NLRP3, inhibits Nigericin-induced IL-1β production, and can be used to study respiratory inflammation or infection.